SynCardia To Bring TAH Ventricular Replacement Before FDA Panel In March
This article was originally published in The Gray Sheet
Executive Summary
SynCardia's CardioWest Total Artificial Heart (TAH) will be reviewed by FDA's Circulatory System Devices panel March 17 in Gaithersburg, Md